中国抗癌协会癌症康复与姑息治疗专业委员会(CRPC);中国临床肿瘤学会抗肿瘤药物安全管理专家委员会(ASMC);
<正>1概述多种抗肿瘤治疗,包括化疗、分子靶向药物治疗、止痛治疗、放疗以及手术等,都可能引起患者恶心呕吐。恶性肿瘤患者并发肠梗阻、水电解质紊乱和脑转移等,也可发生不同程度的恶心呕吐。恶心呕吐对患者的情感、社会和体力功能都会产生明显的负面影响,降低患者的生活质量和对于
| 7,006 | 484 | 61 |
| 下载次数 | 被引频次 | 阅读次数 |
[1]NCCN Clinical Practice Guidelines in Oncology:Antiemesis.version 1.2014[EB/OL].[2014-02-25].http://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf.
[2]MASCC/ESMO.Antiemetic Guidelines 2013[EB/OL].[2014-02-25].http://www.mascc.org/antiemetic-guidelines;2013MASCCTM.
[3]吴昌平,王湛,王杰军,等.单剂量和多次重复剂量盐酸帕洛诺司琼注射液预防化疗所致恶心、呕吐的临床观察[J].临床肿瘤学杂志,2012,17(9):790-794.
[4]Gralla RJ,Osoba D,Krismg,et al.Recommendations for the use of antiemetics:evidence-based,clinical practice guidelines[J].J Clin Oncol,1999,17(9):2971-2994.
[5]徐建国.手术后恶心呕吐(PONV)防治快捷指南[EB/OL].2012[2014-02-25].http://www.csaol.cn/bencandy.php?aid=6246.
[6]Apfel CC,Heidrich FM,Jukar-Rao S,et al.Evidence-based analysis of risk factors for postoperative nausea and vomiting[J].Br J Anaesth,2012,109(5):742-753.
[7]Warr DG,Grunberg SM,Gralla RJ,et al.The oral NK 1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting:Pooled data from 2 randomised,double-blind,placebo controlled trials[J].Eur J Cancer,2005,41(9):1278-1285.
[8]Gralla R,Lichinitser M,Van Der Vegt S,et al.Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy:results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron[J].Ann Oncol,2003,14(10):1570-1577.
[9]Eisenberg P,Figueroa-Vadillo J,Zamora R,et al.Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron,a pharmacologically novel 5-HT3receptor antagonist[J].Cancer,2003,98(11):2473-2482.
[10]Jordan K,Kinitz I,Voigt W,et al.Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapy[J].Eur J Cancer,2009,45(7):1184-1187.
[11]Albany C,Brames MJ,Fausel C,et al.Randomized,doubleblind,placebo-controlled,phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens:a hoosier oncology group study[J].J Clin Oncol,2012,30(32):3998-4003.
[12]陈映霞,秦叔逵,程颖,等.盐酸帕洛诺司琼预防化疗性恶心呕吐的多中心双盲随机对照临床研究[J].临床肿瘤学杂志,2007,12(3):161-165.
[13]杨新杰,张树才.雷莫司琼预防肺癌顺铂化疗所致恶心呕吐效果的随机对照临床研究[J].中国肺癌杂志,2005,8(4):322-325.
基本信息:
DOI：
中图分类号:R730.5
引用信息:
[1]于世英,印季良,秦叔逵等.肿瘤治疗相关呕吐防治指南(2014版)[J].临床肿瘤学杂志,2014,19(03):263-273.
基金信息: